Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2020Cellular and Molecular ImmunologyOpen Access

Clinical development of CAR T cell therapy in China: 2020 update

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJianshu WeiYGYelei GuoYWYao Wang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wei et al. (2020) studied this question.

synapsesocial.com/papers/6a7e74ecef3c205b104f98b8https://doi.org/10.1038/s41423-020-00555-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2–CH3 IgG spacer domains2018 · 44 citations
  2. 2CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia2019 · 254 citations
  3. 3Gene Therapy of Malignant Solid Tumors by Targeting erbB2 Receptors and by Activating T Cells2012 · 11 citations
  4. 4Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials2020 · 384 citations
  5. 5Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia2014 · 364 citations